Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

Authors: Aviram M.; Rosenblat M.; Bisgaier C.L.; Newton R.S.

Source: Atherosclerosis, Volume 138, Number 2, June 1998 , pp. 271-280(10)

Publisher: Elsevier

Buy & download fulltext article:

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Keywords: Lipid peroxidation; LDL; VLDL; HDL; Atorvastatin; Gemfibrozil; Paraoxonase

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0021-9150(98)00032-X

Affiliations: 1: The Lipid Research Laboratory, Technion Faculty of Medicine, The Rappaport Family Institute for Research in the Medical Sciences and Rambam Medical Center, Haifa 31096, Israel

Publication date: 1998-06-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page